Application of streptavidin and plant virus resisting agent

By using antiviral agents that combine streptomycin glucan with other polysaccharides, the problem of poor efficacy in preventing and treating plant virus diseases in the prior art is solved, effective resistance to a variety of plant viruses is achieved, and safety and flexibility are provided. prevention and control plan.

CN119054699APending Publication Date: 2024-12-03SHAANXI DONGWANG NONGHUA BIOTECHNOLOGY CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411360496.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-27
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art is not effective in preventing and treating plant virus diseases, and the use of chemical drugs will cause harm to the ecological environment and lacks safe and effective protection methods.

Method used

Streptomycin-free dextran is used as the main component, combined with chitosan, dextene, oligosaccharide, shiitake polysaccharide and other synergists to prepare anti-plant viruses to improve the plant's tobacco mosaic virus , resistance to cucumber green mosaic virus, tomato yellow vermicelli virus, peanut stripe virus and apple mosaic virus.

Benefits of technology

It significantly improves the resistance of plants to a variety of plant viruses, provides safer and more effective prevention and control solutions, and can be flexibly applied through spraying, powdering, spreading and other methods, and is suitable for different crops and environmental conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119054699A_ABST
    Figure CN119054699A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of microorganisms and pesticides, in particular to application of streptavidin and an anti-plant virus agent. The plant immune resistance inducer is prepared from the streptavidin as an effective active component, the synergist chitosan, the glucosan, the oligosaccharin, the lentinan and the auxiliaries according to a specific proportion, can be used for inducing plants to improve the antiviral activity, and has a wide application prospect in the aspect of preventing and treating plant virus diseases.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of microorganisms and pesticides, and in particular to the application of streptavidin glucan in the preparation of anti-plant virus agents and anti-plant virus agents containing streptavidin glucan. Background Art

[0002] Plant virus diseases are called plant cancers. They are a kind of important disease in agricultural production that is diverse, widespread, and seriously harmful. The degree of harm to crops is second only to fungal pathogens. Almost every crop is harmed by 2 to 3 plant viruses. At present, the main means of preventing and controlling plant virus diseases is chemical control, but chemical control will harm the ecological environment, and the control effect does not meet production requirements.

[0003] Streptavidin-glucan, its structural formula is as follows Figure 1 As shown, the molecular weight is about 14941Da. The polysaccharide part is composed of two monosaccharides, namely glucose and galacturonic acid glucosamine and galactose. The main glycosidic bond structure is: the main chain connection mode is the glycosidic bond of →4)-α-D-Glcp-(1→, and the terminal α-D-Glcp-(1→ is connected to the main chain through the O-6 bond of →4,6)-α-D-Glcp-(1→. Streptococcus immunoglucan has been proven to be able to be used as a plant immune inducer. It can be prepared into a microbial agent and can be used to improve the low potassium tolerance of cucumber, improve the salt tolerance and drought tolerance of wheat, improve the cold tolerance of apple trees and Schisandra chinensis, and alleviate the low germination rate of new shoots caused by frost damage in Schisandra chinensis. Streptococcus immunoglucan is derived from the metabolites of Streptomyces HL-66 and is safe and pollution-free. Whether it has other protective effects on plants deserves further analysis and exploration. Summary of the invention

[0004] The present invention aims to solve the limitations of existing applications of streptavidin glucan. To this end, the present invention provides an application of streptavidin glucan in the preparation of an anti-plant virus agent.

[0005] To achieve the above purpose, the present invention adopts the following technical solution:

[0006] In a first aspect, the present invention provides a use of streptavidin glucan in the preparation of an anti-plant virus agent, wherein the streptavidin glucan has the following structural formula:

[0007]

[0008] Furthermore, the streptavidin glucan is used to improve the antiviral activity of plants.

[0009] Furthermore, the antiviral agent is resistant to tobacco mosaic virus (TMV), cucumber green mottle mosaic virus (Cucumber green mottle mosaic virus), tomato yellow leaf curl virus (TYLCV), peanut stripe virus (PStV) or apple mosaic virus (ApMV).

[0010] Furthermore, the plant is melon, fruit, vegetable, nut or tobacco, such as cucumber, apple, peanut, tomato and the like.

[0011] The second aspect of the present invention provides an anti-plant virus agent, which uses the streptavidin-glucan as the only effective active ingredient.

[0012] Furthermore, the anti-plant virus agent includes a synergist, and the synergist is one or a combination of chitosan, glucan, oligosaccharide, and lentinan.

[0013] Furthermore, the mass ratio of the streptavidin-glucan to the synergist is 1-100:1-100.

[0014] Furthermore, the anti-plant virus agent includes an agriculturally acceptable adjuvant.

[0015] Furthermore, the weight of the auxiliary agent accounts for 60% to 90% of the total weight of the anti-plant virus agent.

[0016] Furthermore, the auxiliary agent is selected from one or more of solvents, dispersants, wetting agents, adhesives, thickeners, antifreeze agents, film formers, binders, surfactants, emulsifiers, and fillers.

[0017] Furthermore, the solvent is selected from one or more of water, benzene, toluene, xylene, methanol, ethanol, glycerol, acetone, glycol ether, soybean oil, ether, ethyl acetate, n-hexane, N-methylpyrrolidone, dimethylformamide, and dimethyl sulfoxide.

[0018] Furthermore, the stabilizer is selected from one or more of citrate, isopropyl phosphate, citric acid, sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, hydrochloric acid, sulfuric acid, phosphoric acid, potassium dihydrogen phosphate, and 1,2-butanediol.

[0019] Furthermore, the surfactant is selected from one or more of fatty alcohol polyoxyethylene ether, sodium lauryl sulfate, sodium dodecylbenzene sulfonate, polyethylene glycol, alkylphenol polyoxyethylene aldehyde, cocamidopropyl betaine, and alkylphenol polyoxyethylene polyoxypropylene ether.

[0020] Furthermore, the antifreeze agent is selected from glycerol, ethylene glycol, and urea.

[0021] Furthermore, the filler is selected from one or more of diatomaceous earth, white carbon black, attapulgite, bentonite or talc.

[0022] The present invention has the following beneficial effects:

[0023] The present invention first discovered that streptavidin glucan can induce fruit trees, melons and leafy vegetables to resist the occurrence of plant virus diseases, especially having a better inhibitory effect on tobacco mosaic virus, cucumber green mottle mosaic virus, tomato yellow leaf curl virus, peanut stripe virus and apple mosaic virus.

[0024] Since viruses replicate and mutate quickly, a single substance acting on plant viruses is likely to produce resistance. The combination of the streptavidin glucan provided by the present invention and a synergist, such as chitosan, glucan, oligosaccharide, lentinan, etc., can further improve the anti-plant virus effect of streptavidin glucan.

[0025] The anti-plant virus agent of the present invention can be flexibly applied according to the growth characteristics of crops, seasonal environmental factors, dosage form types, etc., and can be reasonably applied to plants in appropriate amounts and at appropriate times using several well-known methods such as spraying, powdering, broadcasting, pouring, root irrigation, seed mixing or seedling dipping, and can effectively prevent and control the harm of various plant virus diseases. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 is the structural formula of streptavidin-dextran;

[0027] Figure 2 is the structural formula of chitosan;

[0028] Figure 3 It is the structural formula of glucanose;

[0029] Figure 4 It is the structural formula of oligosaccharide;

[0030] Figure 5 is the structural formula of Lentinan;

[0031] Figure 6 This is a pharmacodynamic diagram of the protective activity of some preparations in Experimental Example 1 against tobacco mosaic virus disease. DETAILED DESCRIPTION

[0032] The present invention is described in detail below in conjunction with the accompanying drawings and specific examples, but they should not be construed as limiting the present invention. Unless otherwise specified, the technical means used in the following examples are conventional means well known to those skilled in the art, and the auxiliary agents, fillers, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial sources.

[0033] Streptavidin glucan was independently isolated by the present invention team and is a metabolite of Streptomyces HL-66. It has been disclosed in Chinese patents (patent numbers 202110797798.7 and 202210663064.4) and is recorded as streptavidin A in the published patents.

[0034] In the published patents, the applications of streptavidin glucan disclosed include improving plant drought resistance, cold resistance, salt tolerance and growth promotion. Streptavidin glucan is derived from the metabolites of Streptomyces HL-66 and is safe and harmless. Whether it has other protective effects on plants deserves further analysis and exploration.

[0035] The invention provides the use of streptavidin glucan in preparing an anti-plant virus agent.

[0036] Furthermore, streptavidin-glucan is used to enhance the antiviral activity of plants.

[0037] Furthermore, the antiviral agent is resistant to tobacco mosaic virus (TMV), cucumber green mottle mosaic virus (Cucumber green mottle mosaic virus), tomato yellow leaf curl virus (TYLCV), peanut stripe virus (PStV) or apple mosaic virus (ApMV).

[0038] The streptavidin glucan of the present invention has a structural formula as follows Figure 1 As shown, the preparation method refers to the method for separating streptavidin A in the patent document with application number 202110797798.7. The molecular formula of chitosan involved in the present invention is (C6H 13 NO5)n, the molecular formula of oligosaccharide is (C6H8O6)n (n=3-40), and the molecular formula of glucan is C 37 H 64 O 31 The molecular formula of Lentinan is (C6H 10 O5)n, the structures of the four compounds are as follows Figure 2 to Figure 5 shown.

[0039] Example 1

[0040] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 1% of streptavidin-glucan, 5% of chitosan, 5% of fatty alcohol polyoxyethylene ether, 3% of glycerol, and water to make up to 100%.

[0041] Example 2

[0042] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 1% of streptavidin glucan, 5% of glucan, 5% of sodium lauryl sulfate, 3% of glycerol, and water to make up to 100%.

[0043] Example 3

[0044] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 1% of streptavidin-glucan, 10% of oligosaccharide, 5% of sodium dodecyl sulfate, 3% of glycerol, and water to make up to 100%.

[0045] Example 4

[0046] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 1% of streptavidin-glucan, 10% of lentinan, 5% of sodium lauryl sulfate, 3% of glycerol, and water to make up to 100%.

[0047] Example 5

[0048] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 1% of streptavidin-glucan, 1% of lentinan, 5% of sodium lauryl sulfate, 3% of glycerol, and water to make up to 100%.

[0049] Example 6

[0050] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 0.1% of streptavidin-glucan, 10% of oligosaccharide, 5% of sodium dodecyl sulfate, 3% of glycerol, and water to make up to 100%.

[0051] Example 7

[0052] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 10% of streptavidin glucan, 0.1% of glucan, 5% of sodium dodecyl sulfate, 3% of glycerol, and water to make up to 100%.

[0053] Example 8

[0054] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 1% of streptavidin-glucan, 50% of chitosan, 5% of sodium lauryl sulfate, 3% of glycerol, and water to make up to 100%.

[0055] Example 9

[0056] An anti-plant virus agent is prepared from the following raw materials by mass fraction: 50% of streptavidin-glucan, 1% of chitosan, 5% of sodium lauryl sulfate, 3% of glycerol, and water to make up to 100%.

[0057] Example 10

[0058] The invention discloses an anti-plant virus agent, which is prepared from the following raw materials by mass fraction: 1% of streptavidin-glucan, 5% of sodium lauryl sulfate, 3% of glycerol, and water to make up to 100%.

[0059] Embodiment 11

[0060] An anti-plant virus agent, which is a 1% aqueous solution of streptavidin glucan by mass.

[0061] Since Examples 1 to 9 all obtained the anti-plant virus agents with the expected effects of the present invention, and the anti-plant virus agents provided by Examples 1 to 9 have basically the same anti-viral effects, the following only uses Examples 1 to 4 and Examples 10 to 11 as examples to illustrate the effects.

[0062] Experimental Example 1

[0063] Determination of the activity of plant virus agents against tobacco mosaic virus (TMV)

[0064] Heartleaf tobaccos at the 3-5 leaf stage with consistent growth were selected to determine the anti-tobacco mosaic virus activity of 0.5, 5, and 10 mg / L aqueous solutions containing the plant virus agents of Examples 1-4 and Examples 10-11, with sterile water as a blank control, and 0.5% chitosan aqueous solution, 0.5% glucan soluble powder, 6% oligosaccharide aqueous solution, 1% lentinan aqueous solution, and 5% amino oligosaccharide aqueous solution as control agents, respectively, with a final virus concentration of 5 μg / mL. The inactivation activity of the plant antiviral agents on viruses, the protective effect on plants, and the therapeutic effect on diseased plants were determined.

[0065] The inactivation activity was to apply the virus to the whole leaf of the heartleaf tobacco after inactivation in vitro for 30 minutes; the protective effect was to spray the whole plant with different concentrations of the agent in the Potter spray tower, and then inoculate TMV by friction 24 hours later; the curative effect was to first inoculate TMV by friction, and then spray the whole plant with different concentrations of the agent 24 hours later. The number of lesions was counted after 2-3 days of greenhouse cultivation, and the prevention effect was calculated.

[0066] The results are shown in Table 1 and Figure 6 As shown in the figure, different formulations have the effects of passivation, protection and treatment on tobacco mosaic virus (disease), and the results are better than those of 5% amino oligosaccharide treatment. The synergistic effect of the mixture was further calculated by the Abbort method. Compared with the single agents of 0.5% chitosan aqueous solution, 0.5% glucan soluble powder, 6% oligosaccharide aqueous solution, and 1% lentinan aqueous solution, the ratio of the actual prevention effect of the mixture to the expected prevention effect measured in the experiment was greater than 1, indicating that streptavidin-glucan has a significant synergistic effect on tobacco mosaic virus disease when combined with other components.

[0067] Table 1 Determination of the activity of anti-plant virus agents against tobacco mosaic virus (TMV)

[0068]

[0069] Note: The data in the table are mean values ​​+ standard errors. Different lowercase letters after the data in the same column indicate significant differences at the 0.05 level tested by Duncan's new multiple range method.

[0070] Experimental Example 2

[0071] Field test of the plant antiviral agents provided in Examples 1, 3, 10 and 11 against apple mosaic disease

[0072] Red Fuji apples were selected, and the cultivation and management conditions of all experimental plots were uniform. The plots were arranged in random blocks, and isolation zones were set between each plot. Each plot had an area of ​​30m 2 , 14 treatments, 3 repetitions. Prepare the liquid for spraying according to the experimental design. Spray the blank control with an equal amount of water. 5% amino oligosaccharides (100 mg / L), 0.5% chitosan aqueous solution and 6% oligosaccharide aqueous solution are positive control agents. Apply the medicine from the young fruit stage, which is the early stage of apple mosaic disease. Each plot is surveyed at 5 points, and 5 branches are sampled at each point. The diseased leaf rate and diseased branch rate are investigated in a graded manner. The disease index of each plot is counted and the incidence rate is calculated. The first application of the medicine was on May 10, 2023, and the application was done 7 days apart, for a total of 3 applications.

[0073] Table 2 Field efficacy determination of plant antiviral agents provided in Examples 1, 3, 10, and 11 against apple mosaic disease

[0074]

[0075]

[0076] Note: The data in the table are mean values ​​+ standard errors. Different lowercase letters after the data in the same column indicate significant differences at the 0.05 level tested by Duncan's new multiple range method.

[0077] As shown in Table 2, the treatments of each agent in Examples 1 and 3 are more effective than those of clean water, and are higher than those of the positive control 5% amino oligosaccharide treatment. Seven days after the third application, the control efficacy of all compound preparations was above 62.7%, while the control efficacy of 5% amino oligosaccharide treatment was only 43.1%. The synergistic effect of the mixture was further calculated by the Abbort method. Compared with the treatments of 0.5% chitosan aqueous solution and 6% oligosaccharide aqueous solution alone, the ratio of the actual control efficacy of the mixture to the expected control efficacy measured in the experiment was greater than 1, indicating that streptavidin immunoglucan has a significant synergistic effect on apple mosaic disease when compounded with chitosan or oligosaccharide.

[0078] Experimental Example 3

[0079] Field efficacy test of the plant antiviral agents provided in Examples 1, 4, 10 and 11 against tomato virus diseases

[0080] The tomato variety for the experiment was Zaofeng. The experiment was carried out in a greenhouse in Dali County under the same cultivation conditions. Tomato virus disease has been serious over the years. After testing, it was found that the tomato virus disease in the area was mainly caused by the Tomato Yellow Leaf Curl Virus. The experiment was carried out during the flowering and fruiting period of tomatoes. There were 14 treatments, with clear water as the blank control, 5% amino oligosaccharides (100 mg / L), 0.5% chitosan aqueous solution and 1% lentinan aqueous solution as the positive control agents. Each plot was about 35m 2 , using randomized block arrangement. Surveys were conducted before, 7d and 14d after application, and 15 tomato plants were randomly surveyed in each plot to investigate the disease situation and calculate the control effect. The first application was on October 5, 2023.

[0081] Table 3 Field efficacy test of plant antiviral agents provided in Examples 1, 4, 10, and 11 against tomato virus diseases

[0082]

[0083] Note: The data in the table are mean values ​​+ standard errors. Different lowercase letters after the data in the same column indicate significant differences at the 0.05 level tested by Duncan's new multiple range method.

[0084] As can be seen from Table 3, 7 days after the third application, the protective effects of each agent treatment were obvious, among which the 10 mg / L plant antiviral agent provided in Examples 1 and 4 can reach 90.4% and 87.2% of the protective effect, and all compound preparations are higher than the positive control 100 mg / L amino oligosaccharide treatment. The synergistic effect of the mixture was further calculated by the Abbort method. Compared with the treatment of 0.5% chitosan aqueous solution and 1% lentinan polysaccharide aqueous solution alone, the ratio of the actual protective effect of the mixture to the expected protective effect measured in the experiment was greater than 1, indicating that streptavidin immunoglucan has a significant synergistic effect on tomato virus disease when compounded with chitosan or lentinan.

[0085] Experimental Example 4

[0086] Field efficacy test of the plant antiviral agents provided in Examples 1, 4, 10 and 11 against cucumber green mottle mosaic virus disease

[0087] The experiment was conducted in Qinliu Village, Linwei District, Weinan City, with the same cultivation conditions. Cucumber green mottle mosaic virus has been seriously infected every year. The experiment was carried out during the flowering and fruiting period of cucumbers. There were 14 treatments, with water as the blank control, 0.5% chitosan water, 0.5% glucan soluble powder and 5% amino oligosaccharide (100 mg / L) as the control agents. One plot was about 22 m 2, using randomized block arrangement. Surveys were conducted before, 7d and 14d after application, and 15 cucumber plants were randomly surveyed in each plot to investigate the disease situation and calculate the prevention effect. The first application was on October 5, 2023.

[0088] Level 0: The whole plant has no symptoms;

[0089] Level 1: A few chlorotic spots or bright veins appear on the leaves;

[0090] Level 3: mosaic of middle and upper leaves;

[0091] Level 5: The middle and upper leaves are heavily mosaic, and a few leaves are wrinkled or deformed;

[0092] Level 7: Most leaves are heavily mosaic, some leaves are wrinkled, deformed or have necrotic spots, and the plant is slightly dwarfed;

[0093] Level 9: Most leaves are severely mosaic, deformed, or have necrotic spots, and the plants are obviously stunted or even dead.

[0094] Table 4 Field efficacy test of plant antiviral agents provided in Examples 1, 4, 10, and 11 against cucumber green mottle mosaic virus disease

[0095]

[0096]

[0097] Note: The data in the table are mean values ​​+ standard errors. Different lowercase letters after the data in the same column indicate significant differences at the 0.05 level tested by Duncan's new multiple range method.

[0098] As can be seen from Table 4, 7 days after the third application, the protective effects of each agent treatment were obvious, among which the 10 mg / L plant antiviral agent provided in Examples 1 and 4 can reach 84.1% and 87.7% of the protective effect, and all the compound treatments of the preparations were higher than the positive control 100 mg / L amino oligosaccharide treatment. The synergistic effect of the mixture was further calculated by the Abbort method. Compared with the treatment of 0.5% chitosan aqueous solution and 0.5% polysaccharide soluble powder alone, the ratio of the actual protective effect of the mixture to the expected protective effect measured in the experiment was greater than 1, indicating that when streptavidin glucan is compounded with chitosan or lentinan, it has a significant synergistic effect on cucumber green mottle mosaic virus disease.

[0099] Experimental Example 5

[0100] Field efficacy test of the plant antiviral agents provided in Examples 3, 4, 10 and 11 against peanut stripe virus disease

[0101] The experiment was conducted in Qinliu Village, Linwei District, Weinan City. The selected plots had been planted with peanuts for 10 years under the same cultivation conditions. Peanut stripe virus disease had occurred seriously over the years. The experiment was carried out during the flowering and fruiting period of peanuts. There were 14 treatments, with water as the blank control, 0.5% polysaccharide soluble powder, 6% oligosaccharide aqueous solution and 5% amino oligosaccharide (100 mg / L) as the positive control agents. Each plot was about 22 m 2 , using randomized block arrangement. Peanut plants were sprayed evenly with an electric sprayer. The seeds were sown on April 22, 2023, and the pesticides were applied on June 2, June 17, and July 2, for a total of 3 times. Surveys were conducted before and 14 days after the last application of the pesticide. Twenty peanut plants were randomly surveyed in each plot to investigate the disease situation and calculate the prevention effect.

[0102] Level 0: The whole plant is disease-free.

[0103] Level 1: Slight mosaic of heart leaves, no obvious dwarfing of diseased plants

[0104] Level 3: The flowers and leaves occupy 1 / 3 of the whole plant, with no obvious dwarfing.

[0105] Level 5: The floral leaves occupy 1 / 3 to 1 / 2 of the entire plant, and the plant is dwarfed to more than 2 / 3 of the normal height.

[0106] Level 7: The floral leaves occupy 1 / 2 to 3 / 4 of the entire plant, and the plant is dwarfed to 1 / 2 to 2 / 3 of the normal height.

[0107] Level 9: The leaves of the entire plant are mosaic, severely deformed or necrotic, or the plant is dwarfed to less than 1 / 2 of the normal height.

[0108] Table 5 Field efficacy of plant antiviral agents provided in Examples 3, 4, 10, and 11 against peanut stripe virus disease

[0109]

[0110]

[0111] Note: The data in the table are mean values ​​+ standard errors. Different lowercase letters after the data in the same column indicate significant differences at the 0.05 level tested by Duncan's new multiple range method.

[0112] As shown in Table 5, the protective effect of each agent treatment is relatively obvious, among which the 10 mg / L plant antiviral agent provided in Examples 3 and 4 can achieve a protective effect of 76.4% and 77.3%. The synergistic effect of the mixture was further calculated by the Abbort method. Compared with the treatment of 0.5% polysaccharide soluble powder and 6% oligosaccharide aqueous solution alone, the ratio of the actual protective effect of the mixture measured in the experiment to the expected protective effect was greater than 1, indicating that when streptavidin glucan is compounded with chitosan or lentinan, it has a significant synergistic effect on peanut stripe virus disease.

[0113] It should be noted that when the patent claims of the present invention involve a numerical range, it should be understood that the two endpoints of each numerical range and any numerical value between the two endpoints can be selected; the pathogens involve common viruses in fruits, vegetables and tobacco. In order to avoid redundancy, the present invention describes a preferred embodiment.

[0114] Although the embodiments of the present invention have been disclosed as above, they are not limited to the applications listed in the specification and the implementation modes, and they can be fully applied to various fields suitable for the present invention. For those familiar with the art, additional modifications can be easily implemented. Therefore, without departing from the general concept defined by the claims and the scope of equivalents, the present invention is not limited to the specific details and the illustrations shown and described herein.

[0115] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. The use of streptavidin glucan in the preparation of an anti-plant virus agent, characterized in that: The streptavidin-glucan structural formula is shown below:

2. The use according to claim 1, characterized in that: The streptavidin glucan is used for improving the antiviral activity of plants.

3. The use according to claim 1, characterized in that: The anti-virus agent is anti-tobacco mosaic virus, cucumber green mottle mosaic virus, tomato yellow leaf curl virus, peanut streak virus or apple mosaic virus.

4. The use according to claim 1, characterized in that: The plants are fruits, vegetables, nuts or tobacco.

5. An anti-plant virus agent, characterized in that: The streptavidin-glucan according to claim 1 is used as the only effective active ingredient.

6. The anti-plant virus agent according to claim 5, characterized in that The anti-plant virus agent comprises a synergist, and the synergist is one or a combination of chitosan, glucan, oligosaccharide, and lentinan.

7. The anti-plant virus agent according to claim 6, characterized in that The mass ratio of the streptavidin-glucan to the synergist is 1-100:1-100.

8. The anti-plant virus agent according to claim 6, characterized in that The anti-plant virus agent includes an agriculturally acceptable adjuvant.

9. The anti-plant virus agent according to claim 8, characterized in that The weight of the auxiliary agent accounts for 60% to 90% of the total weight of the anti-plant virus agent.

10. The anti-plant virus agent according to claim 8, characterized in that The auxiliary agent is selected from one or more of a dispersant, a wetting agent, an adhesive, a thickener, a film former, a binder, a surfactant, an emulsifier, and a filler.

Citation Information

Cited By

  • Agricultural composition of streptavidin and benzimidazole fungicide and application of agricultural composition in prevention and treatment of fungal diseases of plants

    CN122536575A

  • Composition of streptonigrin and inorganic copper and its application in preventing and treating plant diseases

    CN122681106A